U.S. Public Shifts Opinion on Psychedelic Legalization, Survey Reveals

An increasing number of U.S. states are exploring the legalization of psychedelics, as highlighted by the findings from the 2025 RAND Psychedelics Survey (RPS). This groundbreaking survey is the first of its kind to provide a nationally representative assessment of public opinion regarding the legalization of three key psychedelic substances: psilocybin mushrooms, LSD, and MDMA. Conducted by the RAND Corporation, the survey aims to inform policy discussions and establish baseline data for future debates.

The survey asked respondents whether they believe the use of these substances should be legal, the reasons for legalizing them, and the preferred methods of distribution if they were to be legalized. In comparison, respondents were also queried about their views on the legalization of cannabis and cocaine. The results revealed that support for the legal use of psilocybin mushrooms stands at only 23 percent, significantly lower than the 65 percent support for cannabis. For LSD and MDMA, support for legalization hovers around 10 percent.

Examining the historical context, the current support for psilocybin mushrooms mirrors the public opinion on cannabis in the mid-1990s, just before various states began implementing medical cannabis laws. It remains to be seen whether psilocybin will follow a similar trajectory in terms of changing public sentiment or policy reform.

Among U.S. adults who have previously used psilocybin mushrooms, a notable 62 percent endorse its legal use. This is in contrast to 80 percent of adults who have consumed cannabis and support its legality. The survey delves deeper than a simple “yes or no” response, offering richer insights into the nuances of public opinion.

Of the respondents who support the legalization of psilocybin mushrooms, only 42 percent believe that adults should have the freedom to use them for any purpose. Conversely, among those opposed to psilocybin legalization, merely 62 percent assert that its use should be banned for any reason.

When asked about the motivations behind legalizing psilocybin, LSD, and MDMA, addressing mental or physical health conditions emerged as the most widely supported rationale. Additionally, when considering where adults should obtain psilocybin mushrooms if they were legalized, 49 percent of respondents favored use at a medical facility under supervision. Approximately 28 percent supported access through dispensaries, while 23 percent advocated for personal cultivation or foraging.

As discussions around psychedelic legalization continue to evolve across the United States, the findings from the 2025 RAND Psychedelics Survey provide critical insights into shifting public attitudes. The implications of these changes could significantly influence future policy decisions and the broader landscape of substance regulation.